Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, ...

Craft Capital Management LLC acted as underwriter for the Offering (the “Underwriter”). VCL Law LLP acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. securities ...

The U.S. IPO market seems to be cooling off this week, with no major listing planned. This week, Advanced Biomed (ADVB) is ...

Tainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis ...

This week, Advanced Biomed (ADVB) is looking to raise $112M under its initial public offering. The company is developing a portfolio of cancer screening technologies for the Chinese market.

Advanced Biomed Inc. (ADVB) expects to raise $10 million in an initial public offering (IPO) on the week of February 24th, IPO Scoop reports. The company will be issuing 1,900,000 shares at $4.00 ...

With more than three weeks left in the first quarter, the value of med-tech IPOs for 2025 already exceeds the funds raised ...

Hyperspectral imaging is a technology that detects slight differences in color to pinpoint the characteristics and conditions ...